Axa’s Eagle Materials EXP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,697
Closed -$488K 1095
2024
Q3
$488K Sell
1,697
-142
-8% -$35.5K ﹤0.01% 966
2024
Q2
$400K Sell
1,839
-5,658
-75% -$1.39M ﹤0.01% 971
2024
Q1
$2.04M Sell
7,497
-4,336
-37% -$1.02M 0.01% 754
2023
Q4
$2.4M Buy
11,833
+5,633
+91% +$990K 0.01% 699
2023
Q3
$1.03M Sell
6,200
-500
-7% -$90.9K ﹤0.01% 832
2023
Q2
$1.25M Buy
6,700
+2,100
+46% +$334K ﹤0.01% 802
2023
Q1
$675K Sell
4,600
-2,700
-37% -$383K ﹤0.01% 925
2022
Q4
$970K Buy
+7,300
New +$922K ﹤0.01% 889

Other funds holding EXP

Axa's EXP Position: Q4 2024 in Review

Axa sold out of Eagle Materials (EXP) in Q4 2024, closing a stake of 1,697 shares — an estimated $488K sold.

Axa first reported a position in EXP in Q4 2022 and held it in 8 quarters. The position peaked at $2.4M in Q4 2023. 491 funds tracked by Wall St. Rank hold EXP as of Q4 2024.

  • Axa reported no remaining Eagle Materials position as of Q4 2024 after selling out during the quarter.
  • Axa sold 1,697 Eagle Materials shares in Q4 2024, an estimated $488K.
  • Axa first reported a position in Eagle Materials in Q4 2022 and held it in 8 quarters.
  • Axa's Eagle Materials position peaked at $2.4M in Q4 2023.
  • 491 funds tracked by Wall St. Rank held Eagle Materials as of Q4 2024.

Based on Axa's 13F filing for Q4 2024, filed 14 Feb 2025.